Guangxi LiuYao Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Guangxi LiuYao Group heeft een totaal eigen vermogen van CN¥8.3B en een totale schuld van CN¥4.4B, wat de schuld-eigenvermogensverhouding op 53.8% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥22.0B en CN¥13.8B. De EBIT Guangxi LiuYao Group is CN¥1.3B waardoor de rentedekking 7.4 is. Het heeft contanten en kortetermijnbeleggingen van CN¥3.3B.

Belangrijke informatie

53.8%

Verhouding schuld/eigen vermogen

CN¥4.45b

Schuld

Rente dekkingsratio	7.4x
Contant	CN¥3.30b
Aandelen	CN¥8.27b
Totaal verplichtingen	CN¥13.77b
Totaal activa	CN¥22.03b

Recente financiële gezondheidsupdates

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

May 21

Recent updates

Guangxi LiuYao Group's (SHSE:603368) Promising Earnings May Rest On Soft Foundations

Nov 05

Returns On Capital Signal Tricky Times Ahead For Guangxi LiuYao Group (SHSE:603368)

Oct 28

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Intrinsic Value Is Potentially 22% Below Its Share Price

Aug 07

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 04

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥19.5B ) 603368 } overtreffen de korte termijn passiva ( CN¥12.2B ).

Langlopende schulden: De kortetermijnactiva 603368 ( CN¥19.5B ) overtreffen de langetermijnschulden ( CN¥1.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 13.9% ) 603368 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 603368 is de afgelopen 5 jaar gedaald van 64.3% naar 53.8%.

Schuldendekking: De schuld van 603368 wordt niet goed gedekt door de operationele kasstroom ( 15.7% ).

Rentedekking: De rentebetalingen op de schuld van 603368 worden goed gedekt door EBIT ( 7.4 x dekking).

Guangxi LiuYao Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

Recent updates

Guangxi LiuYao Group's (SHSE:603368) Promising Earnings May Rest On Soft Foundations

Third quarter 2024 earnings released: EPS: CN¥0.63 (vs CN¥0.64 in 3Q 2023)

Returns On Capital Signal Tricky Times Ahead For Guangxi LiuYao Group (SHSE:603368)

Guangxi LiuYao Group Co., Ltd to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: CN¥0.42 (vs CN¥0.50 in 2Q 2023)

Now 21% overvalued

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Intrinsic Value Is Potentially 22% Below Its Share Price

Guangxi LiuYao Group Co., Ltd to Report First Half, 2024 Results on Aug 29, 2024

Guangxi LiuYao Group (SHSE:603368) Is Increasing Its Dividend To CN¥0.60

Dividend increased to CN¥0.60

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

Guangxi LiuYao Group's (SHSE:603368) Earnings Are Weaker Than They Seem

New major risk - Financial position

First quarter 2024 earnings released: EPS: CN¥0.83 (vs CN¥0.72 in 1Q 2023)

Guangxi LiuYao Group Co., Ltd, Annual General Meeting, May 17, 2024

A Look At The Fair Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)

Guangxi LiuYao Group Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

Full year 2023 earnings released: EPS: CN¥2.34 (vs CN¥1.94 in FY 2022)

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Investor sentiment improves as stock rises 15%

Guangxi LiuYao Group Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.64 (vs CN¥0.57 in 3Q 2022)

Guangxi LiuYao Group Co., Ltd to Report Q3, 2023 Results on Oct 26, 2023

Price target decreased by 24% to CN¥25.19

Second quarter 2023 earnings released: EPS: CN¥0.50 (vs CN¥0.41 in 2Q 2022)

Now 22% undervalued after recent price drop

Investor sentiment improves as stock rises 22%

Guangxi LiuYao Group Co., Ltd to Report First Half, 2023 Results on Aug 29, 2023

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: EPS: CN¥0.72 (vs CN¥0.61 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥1.91 (vs CN¥1.56 in FY 2021)

Guangxi LiuYao Group Co., Ltd (SHSE:603368) announces an Equity Buyback for CNY 100 million worth of its shares.

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.47 in 3Q 2021)

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to CN¥23.53

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.59 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.34 (vs CN¥0.58 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥1.96 (vs CN¥1.90 in FY 2019)

Guangxi Liuzhou Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: CN¥20.16

New 90-day low: CN¥21.59

Analysts lower EPS estimates to CN¥2.31

Third quarter earnings released

New 90-day low: CN¥22.97

New 90-day low: CN¥23.29

First half earnings released

New 90-day high - CN¥27.40

Guangxi Liuzhou Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven